Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Ovid Therapeutics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 80
- −7 vs. Q1 2021
- Shares held
- 33.4M
- −2.79M (−7.7%) vs. Q1 2021
- Total value
- $130.5M
- −$14.9M (−10.2%) vs. Q1 2021
- New holders
- 21
- 18 more added
- Sold out
- 28
- 30 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OVID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 130 | $395.5M |
| Q1 2026 | 103 | $233.2M |
| Q4 2025 | 84 | $100.2M |
| Q3 2025 | 81 | $47.1M |
| Q2 2025 | 71 | $11.9M |
| Q1 2025 | 82 | $14.5M |
| Q4 2024 | 82 | $44.4M |
| Q3 2024 | 75 | $54.7M |
| Q2 2024 | 74 | $35.4M |
| Q1 2024 | 81 | $152.8M |
| Q4 2023 | 77 | $166.3M |
| Q3 2023 | 64 | $162.6M |
| Q2 2023 | 69 | $134.5M |
| Q1 2023 | 61 | $99.8M |
| Q4 2022 | 60 | $71.7M |
| Q3 2022 | 59 | $65.5M |
| Q2 2022 | 55 | $74.5M |
| Q1 2022 | 62 | $110.3M |
| Q4 2021 | 67 | $109.2M |
| Q3 2021 | 72 | $112.9M |
| Q2 2021 | 80 | $130.5M |
| Q1 2021 | 88 | $145.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Ovid Therapeutics Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quantbot Technologies LP | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −11,254−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −11,262−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −5,199−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,782−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,333−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Fairpointe Capital LLC | – | – | – | – | Not filed |